+1 877 560 8035

info@melanomanetwork.ca

Donate GOLF N GRILL

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation

Tagged: Pembrolizumab (MK-3475)

Viewing 0 reply threads

Author

Posts
- June 2, 2022 at 10:25 am #44087
  
  Mary Zawadzki
  Keymaster
  
  Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
Author

Posts

Viewing 0 reply threads

You must be logged in to reply to this topic.